Clinical Trials for Thrombocytopenia

Hetrombopag for the Thrombocytopenia Induced by Concurrent Chemoradiotherapy

NCT ID: NCT06433830

This clinical trial is studying a medication called hetrombopag to see if it can help patients who have low platelet counts, known as thrombocytopenia, due to treatment with both chemotherapy and r...

The Effect of REcombinant Human Thrombopoietin (rhTPO) on Sepsis Patients With aCUte Severe thrombocytopEnia

NCT ID: NCT02707497

This clinical trial is investigating whether a treatment called recombinant human thrombopoietin (rhTPO) can help patients with sepsis who also have very low platelet levels, a condition known as t...

STrategies for Anticoagulation in Patients With thRombocytopenia and Cancer-associated Thrombosis

NCT ID: NCT05255003

This clinical trial is studying the best way to treat patients with cancer who have blood clots and low platelet counts. Blood clots are common in cancer patients, and they are usually treated with...

Study Comparing Platelet Transfusion Volumes in Premature Babies

NCT ID: NCT06095648

This clinical trial is studying the best amount of platelets to transfuse in premature babies who have low platelet counts, a condition known as thrombocytopenia. Platelets are important for helpin...

Antiplatelet Therapy for AIS Patients With Thrombocytopenia

NCT ID: NCT06053021

This clinical trial is looking at how safe and effective a type of treatment called antiplatelet therapy is for patients who have had an acute ischemic stroke (AIS) and also have a low platelet cou...

Avatrombopag for HCC Patients With Thrombocytopenia Who Intend to Undergo TACE and/or HAIC

NCT ID: NCT06001567

This clinical trial is studying a medication called avatrombopag to see if it can help patients with hepatocellular carcinoma (HCC) who have low platelet counts, a condition known as thrombocytopen...

The Efficacy and Safety of Hetrombopag in Primary Prevention of Thrombocytopenia Induced by the Niraparib Maintenance in Advanced Ovarian Cancer Patients

NCT ID: NCT06036966

This clinical trial is investigating the use of a medication called hetrombopag to help prevent low platelet levels, known as thrombocytopenia, in women with advanced ovarian cancer who are receivi...

Assessment of Risk Factors and Outcome of Thrombocytopenia in ICU Patients

NCT ID: NCT05958511

This clinical trial is focused on understanding the risk factors and outcomes of thrombocytopenia, which means having low platelet counts, in patients who are in the intensive care unit (ICU). Thro...

Function of Platelets Used for Transfusions

NCT ID: NCT05038722